Ekkelenkamp MB - Search Results

1

Unravelling the mechanisms causing murepavadin resistance in Pseudomonas aeruginosa: lipopolysaccharide alterations and its consequences.

Hernández-García M, Barbero-Herranz R, Bastón-Paz N, Díez-Aguilar M, López-Collazo E, Márquez-Garrido FJ, Hernández-Pérez JM, Baquero F, Ekkelenkamp MB, Fluit AC, Fuentes-Valverde V, Moscoso M, Bou G, Del Campo R, Cantón R, Avendaño-Ortiz J. Hernández-García M, et al. Among authors: ekkelenkamp mb. Front Cell Infect Microbiol. 2024 Dec 6;14:1446626. doi: 10.3389/fcimb.2024.1446626. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39711784 Free PMC article.

2

Susceptibility of Pseudomonas aeruginosa Recovered from Cystic Fibrosis Patients to Murepavadin and 13 Comparator Antibiotics.

Ekkelenkamp MB, Cantón R, Díez-Aguilar M, Tunney MM, Gilpin DF, Bernardini F, Dale GE, Elborn JS, Bayjanov JR, Fluit A. Ekkelenkamp MB, et al. Antimicrob Agents Chemother. 2020 Jan 27;64(2):e01541-19. doi: 10.1128/AAC.01541-19. Print 2020 Jan 27. Antimicrob Agents Chemother. 2020. PMID: 31767727 Free PMC article.

3

Murepavadin antimicrobial activity against and resistance development in cystic fibrosis Pseudomonas aeruginosa isolates.

Díez-Aguilar M, Hernández-García M, Morosini MI, Fluit A, Tunney MM, Huertas N, Del Campo R, Obrecht D, Bernardini F, Ekkelenkamp M, Cantón R. Díez-Aguilar M, et al. J Antimicrob Chemother. 2021 Mar 12;76(4):984-992. doi: 10.1093/jac/dkaa529. J Antimicrob Chemother. 2021. PMID: 33367642

4

Anti-biofilm activity of murepavadin against cystic fibrosis Pseudomonas aeruginosa isolates.

Díez-Aguilar M, Ekkelenkamp M, Morosini MI, Huertas N, Del Campo R, Zamora J, Fluit AC, Tunney MM, Obrecht D, Bernardini F, Cantón R. Díez-Aguilar M, et al. J Antimicrob Chemother. 2021 Sep 15;76(10):2578-2585. doi: 10.1093/jac/dkab222. J Antimicrob Chemother. 2021. PMID: 34283223

5

Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.

Díez-Aguilar M, Morosini MI, Köksal E, Oliver A, Ekkelenkamp M, Cantón R. Díez-Aguilar M, et al. Antimicrob Agents Chemother. 2017 Dec 21;62(1):e01650-17. doi: 10.1128/AAC.01650-17. Print 2018 Jan. Antimicrob Agents Chemother. 2017. PMID: 29084746 Free PMC article.

6

Antimicrobial susceptibility of non-fermenting Gram-negative pathogens isolated from cystic fibrosis patients.

Díez-Aguilar M, Ekkelenkamp M, Morosini MI, Merino I, de Dios Caballero J, Jones M, van Westreenen M, Tunney MM, Cantón R, Fluit AC. Díez-Aguilar M, et al. Int J Antimicrob Agents. 2019 Jan;53(1):84-88. doi: 10.1016/j.ijantimicag.2018.09.001. Epub 2018 Sep 19. Int J Antimicrob Agents. 2019. PMID: 30240837

7

Whole-genome analysis of Pandoraea species strains from cystic fibrosis patients.

Bayjanov JR, Ekkelenkamp MB, Rogers MR, Cantón R, Benaissa-Trouw BJ, Díez-Aguilar M, Tunney M, Fluit AC. Bayjanov JR, et al. Among authors: ekkelenkamp mb. Future Microbiol. 2019 Nov;14:1357-1367. doi: 10.2217/fmb-2019-0038. Epub 2019 Nov 25. Future Microbiol. 2019. PMID: 31762328

8

Draft genome sequence of the strain 16-537536, isolated from a patient with bronchiectasis and its relationship to the Pseudomonas koreensis group of the Pseudomonas fluorescens complex.

Fluit AC, Rogers MRC, Díez-Aguilar M, Cantón R, Benaissa-Trouw BJ, Bayjanov JR, Ekkelenkamp MB. Fluit AC, et al. Among authors: ekkelenkamp mb. BMC Res Notes. 2020 Jan 6;13(1):10. doi: 10.1186/s13104-019-4863-2. BMC Res Notes. 2020. PMID: 31907003 Free PMC article.

9

Taxonomic position, antibiotic resistance and virulence factor production by Stenotrophomonas isolates from patients with cystic fibrosis and other chronic respiratory infections.

Fluit AC, Bayjanov JR, Aguilar MD, Cantón R, Elborn S, Tunney MM, Scharringa J, Benaissa-Trouw BJ, Ekkelenkamp MB. Fluit AC, et al. Among authors: ekkelenkamp mb. BMC Microbiol. 2022 May 12;22(1):129. doi: 10.1186/s12866-022-02466-5. BMC Microbiol. 2022. PMID: 35549675 Free PMC article.

10

Taxonomic position, antibiotic resistance and virulence factors of clinical Achromobacter isolates.

Fluit AC, Bayjanov JR, Aguilar MD, Benaissa-Trouw B, Tunney MM, Westreenen MV, Meis JF, Elborn JS, Cantón R, Ekkelenkamp MB. Fluit AC, et al. Among authors: ekkelenkamp mb. Front Biosci (Schol Ed). 2022 Mar 21;14(2):9. doi: 10.31083/j.fbs1402009. Front Biosci (Schol Ed). 2022. PMID: 35730434 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters